BAM
MYOV

Blueshift Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Blueshift Asset Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,396
Closed -$129K – 903
2022
Q2 		$129K Sell
10,396
-11,580
-53% -$128K 0.02% 611
2022
Q1 		$293K Buy
+21,976
New +$295K 0.03% 621
2021
Q4 		– Sell
-126,915
Closed -$2.85M – 1319
2021
Q3 		$2.85M Sell
126,915
-41,175
-24% -$904K 0.16% 174
2021
Q2 		$3.83M Buy
+168,090
New +$3.54M 0.21% 128
2020
Q3 		– Sell
-10,317
Closed -$213K – 817
2020
Q2 		$213K Buy
+10,317
New +$140K 0.03% 464

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Blueshift Asset Management's MYOV Position: Q3 2022 in Review

Blueshift Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q3 2022, closing a stake of 10,396 shares — an estimated $129K sold.

Blueshift Asset Management first reported a position in MYOV in Q2 2020 and held it in 5 quarters. The position peaked at $3.83M in Q2 2021. 98 funds tracked by Wall St. Rank hold MYOV as of Q3 2022.

  • Blueshift Asset Management reported no remaining Myovant Sciences Ltd. position as of Q3 2022 after selling out during the quarter.
  • Blueshift Asset Management sold 10,396 Myovant Sciences Ltd. shares in Q3 2022, an estimated $129K.
  • Blueshift Asset Management first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 5 quarters.
  • Blueshift Asset Management's Myovant Sciences Ltd. position peaked at $3.83M in Q2 2021.
  • 98 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2022.

Based on Blueshift Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.